These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 8442462

  • 1. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ, Maher M.
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [Abstract] [Full Text] [Related]

  • 2. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE, Cacace L, Anderson RJ, Ackerman LA.
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [Abstract] [Full Text] [Related]

  • 3. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM, Daniels CE, Somani SM.
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [Abstract] [Full Text] [Related]

  • 4. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [Abstract] [Full Text] [Related]

  • 5. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR, Olson SM.
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inexpensive microcomputer for intravenous admixture service applications.
    Lang JR.
    Am J Hosp Pharm; 1983 Mar; 40(3):406-8. PubMed ID: 6846347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Time-motion study of intravenous ranitidine admixtures.
    Gonzalez ER, Hruska BM, Elswick RK, Wood CF, Pesko LJ.
    DICP; 1990 Jun; 24(6):590-2. PubMed ID: 2360336
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ, Owen H, Popovich J, Pancorbo S.
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [Abstract] [Full Text] [Related]

  • 16. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ, Fishman DA, Kochis TR.
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacy component of a hospital end-product cost-accounting system.
    Smith JE, Sheaffer SL, Meyer GE, Giorgilli F.
    Am J Hosp Pharm; 1988 Apr; 45(4):835-43. PubMed ID: 3376968
    [Abstract] [Full Text] [Related]

  • 20. Personnel requirements for an outpatient chemotherapy admixture service.
    Waite WW, McDaniel PA, Peak VJ.
    Hosp Pharm; 1986 Dec; 21(12):1150-2, 1158-11. PubMed ID: 10279774
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.